Barcelona-based Biorce, which is developing an AI service to speed up clinical trials, raised a $52.5M Series A, bringing its total funding to $60M+ — The investment will support Biorce's growing demand, international expansion, team growth, and continued development of its AI platform for clinical trials.
Posted from: this blog via Microsoft Power Automate.
